72 related articles for article (PubMed ID: 8076439)
1. Anti-hypertensive effect of low Na connection (120 mEq/l) solution for CAPD patients.
Nakayama M; Kawaguchi Y; Yokoyama K; Kubo H; Miura Y; Watanabe S; Sakai O
Clin Nephrol; 1994 Jun; 41(6):357-63. PubMed ID: 8076439
[TBL] [Abstract][Full Text] [Related]
2. The effect of ultra-low sodium dialysate in CAPD. A kinetic and clinical analysis.
Nakayama M; Yokoyama K; Kubo H; Matsumoto H; Hasegawa T; Shigematsu T; Kawaguchi Y; Sakai O
Clin Nephrol; 1996 Mar; 45(3):188-93. PubMed ID: 8706361
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the sodium concentration of dialysate solution for continuous ambulatory peritoneal dialysis].
Nakayama M
Nihon Jinzo Gakkai Shi; 1992 Aug; 34(8):913-20. PubMed ID: 1484410
[TBL] [Abstract][Full Text] [Related]
4. Low sodium concentration solution in normohydrated CAPD patients.
Amici G; Virga G; Da Rin G; Teodori T; Calzavara P; Bocci C
Adv Perit Dial; 1995; 11():78-82. PubMed ID: 8534744
[TBL] [Abstract][Full Text] [Related]
5. Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances.
Song JH; Park GH; Lee SY; Lee SW; Lee SW; Kim MJ
J Am Soc Nephrol; 2005 Jan; 16(1):237-46. PubMed ID: 15563561
[TBL] [Abstract][Full Text] [Related]
6. Mild sodium reduction in peritoneal dialysis solution improves hypertension in end stage kidney disease: a case-report study.
Vecchi L; Bonomini M; Palumbo R; Arduini A; Borrelli S
BMC Nephrol; 2021 May; 22(1):170. PubMed ID: 33964894
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal functional changes induced by dialysate containing bicarbonate instead of lactate.
Selgas R; Bajo MA; Fernandez-Reyes MJ; Jimenez C; Del Peso G; Sanchez C; de Alvaro F
Adv Perit Dial; 1996; 12():49-52. PubMed ID: 8865872
[TBL] [Abstract][Full Text] [Related]
8. Advantages of HCO3 solution with low sodium concentration over standard lactate solutions for acute peritoneal dialysis.
Vande Walle J; Raes A; Castillo D; Lutz-Dettinger N; Dejaegher A
Adv Perit Dial; 1997; 13():179-82. PubMed ID: 9360677
[TBL] [Abstract][Full Text] [Related]
9. The role of sequential ultrafiltration and varying dialysate sodium on vascular stability during hemodialysis.
Po CL; Afolabi M; Raja RM
ASAIO J; 1993; 39(3):M798-800. PubMed ID: 8268648
[TBL] [Abstract][Full Text] [Related]
10. [Sodium kinetics in peritoneal dialysis: from theory to clinical practice].
La Milia V
G Ital Nefrol; 2006; 23(1):37-48. PubMed ID: 16521074
[TBL] [Abstract][Full Text] [Related]
11. A detailed analysis of sodium removal by peritoneal dialysis: comparison with predictions from the three-pore model of membrane function.
Aanen MC; Venturoli D; Davies SJ
Nephrol Dial Transplant; 2005 Jun; 20(6):1192-200. PubMed ID: 15827048
[TBL] [Abstract][Full Text] [Related]
12. Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients.
Velasquez MT; Lew SQ; von Albertini B; Mishkin GJ; Bosch JP
Clin Nephrol; 1997 Dec; 48(6):341-5. PubMed ID: 9438091
[TBL] [Abstract][Full Text] [Related]
13. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
14. Low Na concentration solution for CAPD.
Nakayama M; Hasegawa T; Kubo H; Yamamoto H; Shigematsu T; Kawaguchi Y; Sakai O
Clin Nephrol; 1996 Jan; 45(1):66-8. PubMed ID: 8616961
[No Abstract] [Full Text] [Related]
15. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
16. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
Kim S; Oh J; Kim S; Chung W; Ahn C; Kim SG; Oh KH
Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
[TBL] [Abstract][Full Text] [Related]
17. [The effect of dialysis solutions containing amino acids on the nutritional status of patients treated with continuous ambulatory peritoneal dialysis].
Opatrná S; Liska J; Vít L; Hostasová A; Opatrný K
Cas Lek Cesk; 1997 Jun; 136(13):409-12. PubMed ID: 9333515
[TBL] [Abstract][Full Text] [Related]
18. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
[TBL] [Abstract][Full Text] [Related]
19. Optimum electrolyte composition of a dialysis solution.
Rippe B; Venturoli D
Perit Dial Int; 2008 Jun; 28 Suppl 3():S131-6. PubMed ID: 18552243
[TBL] [Abstract][Full Text] [Related]
20. Polyglucose dialysis solution induces changes in blood chemistry.
Grzegorzewska AE; Antczak-Jedrzejczak D; Leander M; Mariak I
Adv Perit Dial; 2001; 17():101-8. PubMed ID: 11510254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
